annb0t
Top 20
Charles River Laboratories International, Inc. CRL reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.66, which rose 8.1% year over year. The figure surpassed the Zacks Consensus Estimate by 6.4%.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
On a GAAP basis, the company reported a loss of $4.22 per share against the year-ago quarterâs earnings of $3.62 per share.
The company reported full-year 2024 EPS of $10.32, which decreased 3.3% from th...
>>> Read more: CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
On a GAAP basis, the company reported a loss of $4.22 per share against the year-ago quarterâs earnings of $3.62 per share.
The company reported full-year 2024 EPS of $10.32, which decreased 3.3% from th...
>>> Read more: CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
